Short answer
Tempus AI Inc (TEM) filed its Q3 2026 10-Q quarterly report on Nov 2, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $412M (up 23.1% year over year) with net income of −$15M.
Q3 2026 key financials · XBRL
- Revenue
- $412M
- +23.1% YoY · +7.6% QoQ
- Net income
- −$15M
- +81.4% YoY · −363.2% QoQ
- Operating margin
- -13.8%
- EPS (diluted)
- −$0.08
- +82.6% YoY · −300.0% QoQ
Source: XBRL data from the Tempus AI Inc (TEM) Q3 2026 10-Q on SEC EDGAR. USD.
Tempus AI Inc Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Quarterly revenue $411.5M, up $77.3M from $334.2M YoY
- Diagnostics revenue $303.5M vs $252.9M, strongest segment, driven by oncology testing
- Data and applications revenue $108.1M vs $81.3M, increased Insights and Next demand
- Net loss $14.9M vs $80.0M, adjusted EBITDA $25.6M vs $1.5M
- Cash, equivalents and restricted cash $595.2M; operating cash use $71.6M, 2032 Notes proceeds $443.1M
- Near-term losses expected, with higher expenses for offerings, sales expansion and marketing; tariffs may raise technology costs
Risk Factors
- New acquisition risk: Proposed Personalis deal may terminate if not completed by April 20, 2027, potentially triggering a $76.8 million fee
- Regulatory risk: Acquisition requires Personalis stockholder approval, regulatory clearances, and Nasdaq listing approval
- Operational risk: Integration may disrupt operations through employee, client, vendor, and service-provider losses
- Financial risk: Convertible Notes total $1.21 billion, with cash conversion potentially reducing liquidity
- Market risk: Failed acquisition could negatively affect Class A share price and results of operations
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.